AbbVie Inc. (ABBV) Q3 2018 Earnings Results

AbbVie Beats on EPS, Stock Down 0.81%

AbbVie's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 0.81% following the announcement, likely due to the lack of revenue details and guidance. Investors may be cautious given the absence of specific future projections.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.14	N/A	+5.34%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized the importance of their product pipeline despite current market challenges.

Management highlighted the strength of their pipeline and ongoing product performance.

They acknowledged challenges in the market but expressed confidence in long-term growth.

AbbVie Beats on EPS, Stock Down 0.81%

Key numbers

Management commentary

AbbVie Inc.

More earnings this week

AbbVie Beats on EPS, Stock Down 0.81%

Key numbers

Management commentary